Our results showed that IFITM1 overexpression reduced EBV infection by ~70% compared with control cells, whereas EphA2 overexpression doubled the EBV copy number in cells, and their co-overexpression reduced this effect (Fig. 3a). This evidence concerns the gene EPHA2 and Epstein-Barr virus infection.